Comparison of 4F‐PCC in obese and nonobese patients with life‐threatening bleeding or requiring emergent surgery-Reference-Cited by-同舟云学术

Comparison of 4F‐PCC in obese and nonobese patients with life‐threatening bleeding or requiring emergent surgery

Published:2021-11-26 Issue:8 Volume:5 Page:
ISSN:2475-0379
Container-title:Research and Practice in Thrombosis and Haemostasis
language:en
Short-container-title:Res Pract Thromb Haemost

Author:

Rimsans Jessica¹^ORCID,Berger Karen²,Culbreth Sarah¹,Hood Christopher³,Chester Katleen⁴,Connors Jean M.⁵^ORCID,Omert Laurel⁶

Affiliation:

1. Department of Pharmacy Services Brigham and Women’s Hospital Boston Massachusetts USA

2. Department of Pharmacy NewYork‐Presbyterian Hospital/Weill Cornell Medical Center New York New York USA

3. Medical Affairs CSL Behring King of Prussia Pennsylvania USA

4. Department of Pharmacy Grady Memorial Hospital Atlanta Georgia USA

5. Division of Hematology Brigham and Women’s Hospital Boston Massachusetts USA

6. Hemanext Inc Lexington Massachusetts USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rth2.12624

Reference18 articles.

1. Kcentra®prescribing information. [Accessed 2020 June 17]. Available fromhttp://cslbehring.vo.llnwd.net/o33/u/central/PI/US/Kcentra/EN/Kcentra‐Prescribing‐Information.pdf

2. Estimating Blood Volume in Obese and Morbidly Obese Patients

3. Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal

4. Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding

5. Fixed dose 4-factor prothrombin complex concentrate for the emergent reversal of warfarin: a retrospective analysis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance Review;Thrombosis and Haemostasis;2024-07-29

2. Dosing Medications for Coagulopathy Reversal in Patients with Extreme Obesity;The Journal of Emergency Medicine;2022-10

3. Variables associated with adequate INR reversal in warfarin treated patients receiving 4-factor prothrombin complex concentrate;Journal of Thrombosis and Thrombolysis;2022-04-04